Dosimetric Comparison Study of Proton Therapy Using Line Scanning versus Passive Scattering and Volumetric Modulated Arc Therapy for Localized Prostate Cancer.

Autor: Takagi M; Department of Radiation Oncology, Sapporo Teishinkai Hospital, Sapporo 065-0033, Japan., Hasegawa Y; Department of Radiation Physics, Sapporo Teishinkai Hospital, Sapporo 065-0033, Japan., Tateoka K; Department of Radiation Physics, Sapporo Teishinkai Hospital, Sapporo 065-0033, Japan., Takada Y; Department of Radiation Oncology, Sapporo Teishinkai Hospital, Sapporo 065-0033, Japan., Hareyama M; Department of Radiation Oncology, Sapporo Teishinkai Hospital, Sapporo 065-0033, Japan.
Jazyk: angličtina
Zdroj: Cancers [Cancers (Basel)] 2024 Jan 17; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 17.
DOI: 10.3390/cancers16020403
Abstrakt: Background: The proton irradiation modality has transitioned from passive scattering (PS) to pencil beam scanning. Nevertheless, the documented outcomes predominantly rely on PS.
Methods: Thirty patients diagnosed with prostate cancer were selected to assess treatment planning across line scanning (LS), PS, and volumetric modulated arc therapy (VMAT). Dose constraints encompassed clinical target volume (CTV) D98 ≥ 73.0 Gy (RBE), rectal wall V65 < 17% and V40 < 35%, and bladder wall V65 < 25% and V40 < 50%. The CTV, rectal wall, and bladder wall dose volumes were calculated and evaluated using the Freidman test.
Results: The LS technique adhered to all dose limitations. For the rectal and bladder walls, 10 (33.3%) and 21 (70.0%) patients in the PS method and 5 (16.7%) and 1 (3.3%) patients in VMAT, respectively, failed to meet the stipulated requirements. The wide ranges of the rectal and bladder wall volumes (V10-70) were lower with LS than with PS and VMAT. LS outperformed VMAT across all dose-volume rectal and bladder wall indices.
Conclusion: The LS method demonstrated a reduction in rectal and bladder doses relative to PS and VMAT, thereby suggesting the potential for mitigating toxicities.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje